IGF1 and Insulin resistance: (3) Metabolic dysregulation: Additional contributors include insulin resistance, oxidative stress, overactivation of the renin-angiotensin-aldosterone system, and impaired insulin-like growth factor 1 (IGF-1) signaling—all of which may amplify cardiovascular risk in this population (46–48).